Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation

BACKGROUND: The Intergroup Exemestane Study (IES) (ISRCTN11883920) demonstrated improved survival for postmenopausal women with ER-positive/unknown primary breast cancer who switched to exemestane after 2–3 years tamoxifen, compared with those continuing on tamoxifen to complete 5 years therapy. Thi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fallowfield, L J, Kilburn, L S, Langridge, C, Snowdon, C F, Bliss, J M, Coombes, R C
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2012
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3304414/
https://ncbi.nlm.nih.gov/pubmed/22353807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.43
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars